The News Review:
- Medicis Impax settle acne drug dispute
- Dirt on cat’s chin might be feline acne ringworm or mange
- Sagentia Undertakes Full ‘Concept Through to Manufacture …
- Sagentia Develops LED-based Acne Treatment Lamp for Photocure
- 5 Simple Tips to Clear Your Acne
- Minocycline for Acne and Autoimmune Disease
Medicis Impax settle acne drug dispute
CNNMoney.com
said late Monday it cut a deal with potential competitor Impax Laboratories Inc. that ends a patent dispute over a generic version of the acne drug Solodyn and has the companies developing a more advanced version of the treatment. Earlier this year Impax Laboratories asked the Food and Drug Administration to approve its version of Solodyn sparking a patent dispute with the drug’s maker Medicis. Under a settlement and contract deal the companies are ending all legal disputes over the drug’s patents and Impax has the right to market a generic version no later than November 2011. After launching its version Impax will pay Medicis a royalty based on sales. Also the companies will jointly develop five dermatology products including an advanced form Solodyn.
Related from Spamblockermonster: Tips to avoid cheats online
Dirt on cat’s chin might be feline acne ringworm or mange
Muncie Star Press IN
I’ve tried unsuccessfully to wash it off but it’s still there. What can I do to give my kitty king a clean chin?. Smith a veterinarian at the Animal Medical Center. This condition in cats results from the formation of comedones (blackheads) in the skin on the front of a cat’s chin. Some cats can be affected minimally with just a “dirty chin” appearance while others might develop a more severe version with the formation of crusts small abscesses or draining tracts. Symptoms will vary according to the disease severity from no symptoms to severe itching and self-trauma.
Sagentia Undertakes Full ‘Concept Through to Manufacture …
Solid State Lighting Net TX
Photocure selected Sagentia for ‘Concept to Manufacture’ development of its Photodynamic Treatment (PDT) Lamp for treament of moderate to severe facial acne – available for use in Phase III clinical trials in the U. in the first half of 2009Maple Lawn Maryland — Sagentia the world leading product development technology consulting and IP exploitation company with U. offices in Maple Lawn Maryland and corporate headquarters in Cambridge UK has deployed its full concept through to manufacture service to deliver the rapid development of a new Photodynamic Treatment (PDT) lamp.
Sagentia Develops LED-based Acne Treatment Lamp for Photocure
Solid State Lighting Net TX
style2 {font-size: 12px}. style3 { font-family: Arial Helvetica sans-serif; color: #666666;}–> All site format content and technology copyright 2001-2008 by CompoundSemi Online Inc. Subject to recognized fair use copyright standards reproduction in whole or part by other than authorized clients is prohibited. Commercial search engines are authorized for all site links. Links for any other commercial purpose are limited to the home and events pages unless you are a client of Solid State Lighting Net or CompoundSemi Online Inc.
5 Simple Tips to Clear Your Acne
Best Syndication CA
Here is the proceedure: 1. Cleaning your face with cleanser five times a day. You thought that acne is a result of bad hygiene.
Minocycline for Acne and Autoimmune Disease
AAP Grand Rounds (registration) IL
013The first 20% of the full text of this article appears below. PICO*Question: Among adolescents treated with minocycline for acne what autoimmune phenomena may occur?Question type: PrognosisStudy design: Case series To assess the association of minocycline with autoimmunity investigators at the Boston Children’s Hospital and Harvard Medical School report a case series of patients who developed a variety of symptoms suggestive of rheumatologic disease while receiving minocycline for acne vulgaris. Study children were identified by reviewing the medical records of children undergoing ANCA (antineutrophil cytoplasmic antibody) testing at a pediatric rheumatology practice between 1996 and 2006. Minocycline-induced autoimmunity (MIA) was defined as a history of minocycline usage and clinical and laboratory findings suggestive of autoimmunity. Patients with MIA were divided into three categories on the basis of disease duration after discontinuation of minocycline: transient (if they responded to minocycline withdrawal or required less than one month of nonsteroidal antiinflammatory drugs [NSAIDs] or corticosteroids); intermediate (if they required one month to one year of treatment); or.